Get the Daily Brief
Latest Biotech News
Dealmaking and commercial funding in obesity and respiratory immunology
Two transactions spotlight how late-stage obesity and respiratory immunology assets are attracting fresh capital and strategic attention. Blackstone committed $1.5 billion to back Pfizer’s...
GLP-1 telehealth conflict-of-interest scrutiny
Eli Lilly’s GLP-1 telehealth ecosystem is drawing fresh conflict-of-interest questions after Oura agreed to buy Counsel Health, the platform Lilly lists for patients seeking GLP-1...
Clinical: immunocompromised strategy with AZD7442 plus bivalent COVID-19 vaccination
A multicenter Phase II RAPID-PROTECTION trial reports that combining the long-acting monoclonal antibody AZD7442 with a bivalent Ancestral/BA.1 mRNA/LNP COVID-19 vaccine was well tolerated in...
FDA and regulatory timeline risk for drug review acceleration
The US FDA has shelved a “Commissioner’s National Priority Voucher” fast-track concept aimed at compressing drug review timelines to roughly one to two months, according to Reuters sources citing...
Biomarker and diagnostic signal: PSMA-1007 bladder activity vs PSMA-11
A retrospective comparison suggests fluorine-18 PSMA-1007 PET/CT produces urinary bladder activity comparable to gallium-68 PSMA-11, potentially complicating lesion interpretation for recurrent...
Oncology imaging and computation: AI margin assessment after liver ablation
An intraprocedural CT–based AI pipeline can quantify ablative margins during radiofrequency ablation and predict local tumor progression after treatment for hepatocellular carcinoma. The...
Microbiology and antimicrobial resistance: rapid carbapenemase detection from blood
A new workflow enables rapid detection of major carbapenemases directly from positive blood cultures in under 25 minutes using the NG-TEST Blood Culture PREP Kit and NG-TEST CARBA 5. The approach...
Diagnostics workflow performance: automated injection lowers confidence in parathyroid PET
A retrospective analysis finds that automated injection for [18F]fluorocholine PET/CT is associated with higher venous retention, lower SUVmax values, and reduced diagnostic confidence compared...
AI-enabled diagnostic imaging: lung ultrasound B-lines estimate filling pressures
A prospective clinical study reports that lung ultrasound B-lines can accurately estimate left ventricular filling pressures and improve diagnostic specificity when integrated into heart failure...
Funding: Biomatter raises $18M to scale AI-designed enzyme manufacturing
Biomatter closed an oversubscribed Series A to raise $18 million, aiming to scale its design-and-deliver enzyme business built around AI-designed reaction outcomes. The company says its enzyme...
Funding and company moves in obesity
Blackstone agreed to invest $1.5 billion behind Pfizer’s obesity program centered on berobenatide, a monthly injectable GLP-1 therapy being developed for chronic weight management and...
Regulatory and clinical progress for inflammation-targeting asthma
Windward Bio raised $175 million in an IPO to advance its ultra-long-acting, inflammation-targeting asthma candidate WIN378, designed to modulate TSLP. The company said interim Phase 2/3 asthma...
Telehealth conflict-of-interest questions emerge from a smart-ring acquisition
Oura’s acquisition of health tech startup Counsel Health is raising conflict-of-interest concerns for Eli Lilly, as experts say GLP-1 drugmakers increasingly promote telehealth prescribers. Lilly...
Ongoing trial activity and filings in immunology
Regeneron reported mid-stage data for baloncibart in POTS, describing an average 11.4-beat-per-minute reduction at the 450 mg dose along with additional updates from the broader immunotherapy...
Cost-cutting and leadership changes after FDA approval
Milestone Pharmaceuticals said it is cutting 20% of staff and leadership headcount following FDA approval of its heart arrhythmia treatment, with two top executives departing its leadership team....
Clinical evidence: semaglutide generics land non-inferiority data in India
A multicenter Phase 3 trial in India found that generic semaglutide delivered non-inferior blood sugar reduction and comparable weight loss versus the innovator product in adults with type 2...
Diagnostic tool: AI margin assessment to predict recurrence after liver ablation
Researchers presented a retrospective case-control study showing that an AI pipeline can automatically quantify ablative margins on intraprocedural CT and predict local tumor progression after...
Regulatory-adjacent policy and drug review timelines in the US
US FDA has shelved the Commissioner's National Priority Voucher program, sources told Reuters, removing a fast-track drug review initiative aimed at cutting review timelines to roughly one to two...
Emerging investment and platform-building in AI-for-biology
Tolemy Bio, an AI-in-bio startup, raised a €1.54 million ($1.54m) pre-seed round, bringing total funding to €1.4 million, per an interview report. The company attributed investor interest to a...
New IPO and clinical pipeline debut in immune respiratory disease
Windward Bio’s IPO not only provides cash but also offers market validation for a TSLP-centered approach in severe asthma. The company’s lead program WIN378 targets an inflammatory protein in an...